Assessment of the Safety and Performance of a Compression Knee Support in the Prevention of Injuries During Sports Practice

Sponsor
Decathlon SE (Industry)
Overall Status
Recruiting
CT.gov ID
NCT04601168
Collaborator
EFOR, France (Industry)
30
2
11.2
15
1.3

Study Details

Study Description

Brief Summary

Decathlon has developed kneeSOFT100 product which is medical device designed to reduce pain and joint instability during sport practice. The objective of this multicentre study is to collect data on the related clinical complications and clinical outcomes of market-approved Decathlon kneeSOFT100 product to demonstrate safety and performance of this device in a real-world setting.

Condition or Disease Intervention/Treatment Phase
  • Device: kneeSOFT100

Study Design

Study Type:
Observational
Anticipated Enrollment :
30 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Assessment of the Safety and Performance of a Compression Knee Support in the Prevention of Injuries During Sports Practice
Actual Study Start Date :
Mar 25, 2021
Anticipated Primary Completion Date :
Mar 1, 2022
Anticipated Study Completion Date :
Mar 1, 2022

Outcome Measures

Primary Outcome Measures

  1. Functional score [6 weeks of follow-up]

    Comparison of the functional result (Lysholm Score: 0-100 points) between the baseline and last follow-up visit

Secondary Outcome Measures

  1. Confidence level [At baseline and 6 weeks of follow-up]

    Gap in the confidence level (patient rated outcome with 6 questions, ranging from 0 to 100) related to physical activity, between the baseline and last follow-up visit

  2. Knee instability [At 2 weeks and 6 weeks of follow-up]

    Comparison of knee instability between the first two weeks of follow-up (without use of the device during sports sessions) and the following four weeks (with use of the device during sports sessions), measured through a visual analog scale (VAS, ranging from 0 to 10)

  3. Knee pain [At 2 weeks and 6 weeks of follow-up]

    Comparison of knee pain between the first two weeks of follow-up (without use of the device during sports sessions) and the following four weeks (with use of the device during sports sessions), measured through a VAS (ranging from 0 to 10)

  4. Safety (adverse events) [6 weeks of follow-up]

    Rate of adverse events occurred during the study

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subject is aged ≥18 years old

  • Subject has chronic pain AND / OR chronic knee instability

  • The current condition of his/her knee allows the subject to resume usual physical activity

  • Subject has been informed and is willing to sign an informed consent form

  • Subject is willing to comply with protocol requirements and return to the study center for all clinical evaluations and required follow-up (6 weeks)

  • Subject is affiliated to the French social security regime

Exclusion Criteria:
  • Subject has conditions that may interfere with his/her ability to understand protocol requirements, participate in scheduled visits, or provide his/her informed consent

  • Subject has worn a support (knee brace or articulated orthosis) during sports sessions during the last month

  • Subject has any medical condition that could impact the study at investigator's discretion

  • Subject has a known hypersensitivity or allergy to the components of the device (elastodiene, polyester)

  • Adult subject to a legal protection measure

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier Régional Universitaire de Lille Lille France 59000
2 KOSS Paris 8 Paris France

Sponsors and Collaborators

  • Decathlon SE
  • EFOR, France

Investigators

  • Principal Investigator: André THEVENON, Centre Hospitalier Régional, Universitaire de Lille
  • Principal Investigator: Thibault VIGNAIS, KOSS Paris 8

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Decathlon SE
ClinicalTrials.gov Identifier:
NCT04601168
Other Study ID Numbers:
  • kneeSOFT100
First Posted:
Oct 23, 2020
Last Update Posted:
Aug 23, 2021
Last Verified:
Aug 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Aug 23, 2021